Yu‐Tao Hu
-
- Adipose Tissue and Metabolism 4
-
- Liver Disease Diagnosis and Treatment 4
-
- Metabolism, Diabetes, and Cancer 4
- CRISPR and Genetic Engineering 3
- Heat shock proteins research 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- Pharmacology and Obesity Treatment 2
-
- Sirtuins and Resveratrol in Medicine 2
In The Last Decade
Yu‐Tao Hu
19 papers receiving 410 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Physiology 111
- Epidemiology 129
- Molecular Biology 253
- Biological Psychiatry 8
- Endocrinology, Diabetes and Metabolism 49
Countries citing papers authored by Yu‐Tao Hu
This map shows the geographic impact of Yu‐Tao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Tao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Tao Hu more than expected).
Fields of papers citing papers by Yu‐Tao Hu
This network shows the impact of papers produced by Yu‐Tao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Tao Hu. The network helps show where Yu‐Tao Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu‐Tao Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 16 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 1 | |
| 16 | Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axisbreakdown → | 2021 | 242 |
| 17 | 2020 | 12 | |
| 18 | 2019 | 16 | |
| 19 | 2019 | 31 | |
| 20 | 2018 | 14 |
About Yu‐Tao Hu
Yu‐Tao Hu is a scholar working on Aging, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism, having authored 22 papers that have together received 411 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Adipose Tissue and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (4 papers), CRISPR and Genetic Engineering (3 papers), Heat shock proteins research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pharmacology and Obesity Treatment (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Physiology (111 citations), Epidemiology (129 citations) and Molecular Biology (253 citations). Yu‐Tao Hu has collaborated with scholars based in China, Australia and Taiwan. Frequent co-authors include Zhi‐Shu Huang, Yao‐Hao Xu, Yong Rao, Ji‐Ming Ye, Bingbing Song, Chan Li, Shi‐Yao Guo, Dandan Zhao, Zhi Jiang and Chengdao Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.